Adaptimmune Therapeutics plc ADAP
0.05 0.00 (+0.00%)
Nov 21, 2025, 9:30 AM EST
0.0425 Day range 0.0599
52-week range unavailable
- YTD
- -91.00%
- 1 year
- -93.42%
Revenue & Expenses
Latest period ending Dec 31, 2024 · select a line to chart its full history
Income statement
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| 178.03M | 60.28M | 27.15M | 6.15M | 3.96M | |
| 177.96M | 60.28M | 27.15M | 6.15M | 3.96M | |
| -68.76M | -139.74M | -163.97M | -162.25M | -133.41M | |
| -70.81M | -113.87M | -165.46M | -158.09M | -130.09M | |
| -0.30 | -0.54 | -1.02 | -1.02 | -0.90 |
Balance sheet
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| 93.21M | 147.02M | 109.60M | 151.67M | 61.48M | |
| 245.96M | 282.62M | 328.92M | 469.55M | 451.14M | |
| 234.11M | 243.10M | 247.04M | 263.58M | 109.92M | |
| 74.21M | 25.23M | 23.08M | 25.47M | 23.71M | |
| 11.85M | 39.51M | 81.88M | 205.96M | 341.23M |
Cash flow
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| -73.21M | -140.88M | -141.77M | 10.73M | -53.59M | |
| -58.95M | 176.54M | 89.14M | 75.80M | -278.92M | |
| 78.75M | 880.00K | 12.87M | 3.29M | 340.05M | |
| -886.00K | -4.68M | -29.50M | -8.57M | -2.34M | |
| -53.81M | 37.41M | -42.06M | 90.18M | 6.58M |